Genomed

Among our clients are all the eminent scientific and medical Polish centers. Since the beginning of 2010 till the end of 2012, the company has been commissioned by the Institute of Mother and Child to perform DNA sequencing and the diagnostic analysis of the gene related to cystic fibrosis as part of the national newborn screening program. Every new year is witness to an improvement in the company's financial results. In 2009, the Genomed's revenue amounted to 1.7 million PLN, in 2010 the company gained an almost 3.9 million PLN gross income and a 0.3 million PLN net profit, whereas in 2011 Genomed"s revenue increased to 4,6 million PLN. Genomed is the only company operating in the field of DNA analysis technology that has made a profit already in the third year of its activity. On the 30th of December 2010, Genomed transformed from a limited liability company into a joint-stock one. In March 2011, the company successfully carried out a private offer and acquired 3 million PLN from investors. Genomed celebrated its debut on the NewConnect market on the 30th of May 2011. OUR AIMS